MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Soleno Therapeutics Total Current Liabilities 2011-2026 | SLNO
Annual Total Current Liabilities Soleno Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.4 M | 18.7 M | 11.5 M | 7.31 M | 8.01 M | 8.62 M | 4.96 M | 1.88 M | 1.73 M | 1.71 M | 3.19 M | 1.29 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.4 M | 1.29 M | 10.9 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 98.33 | 0.9 % | $ 8.11 B |  Irlanda |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 155.46 | 1.83 % | $ 7.71 B | USA |
 |
Bioventus
BVS
|
160 M | $ 8.62 | 0.23 % | $ 574 M | USA |
 |
DexCom
DXCM
|
2.14 B | $ 64.24 | -1.56 % | $ 25.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 25.56 | 0.95 % | $ 710 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 17.01 | 3.4 % | $ 906 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | $ 103.57 | 0.29 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
303 M | $ 85.49 | 1.75 % | $ 10.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 14.77 | 0.61 % | $ 447 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 17.88 | -6.63 % | $ 2.32 B | USA |
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 2.83 | -1.05 % | $ 91.8 K | USA |
 |
Danaher Corporation
DHR
|
6.81 B | $ 187.32 | 0.57 % | $ 134 B | USA |
 |
IQVIA Holdings
IQV
|
8.34 B | $ 164.72 | 1.1 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 118.94 | 2.92 % | $ 18.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 199.7 | -0.46 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
1.71 B | $ 111.51 | -0.06 % | $ 33.9 B | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.11 | -0.89 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 9.0 | -0.99 % | $ 255 M |  Israel |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.09 | -2.78 % | $ 1.97 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 16.52 | 0.12 % | $ 370 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.33 | 4.72 % | $ 399 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | - | - | $ 79.8 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 450.41 | 1.48 % | $ 13 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 114.22 | 3.11 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 173.74 | 0.49 % | $ 24.2 B |  Schweiz |
 |
Personalis
PSNL
|
31.1 M | $ 6.72 | 1.97 % | $ 398 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 7.88 | -1.25 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
310 M | $ 187.85 | -1.29 % | $ 18.5 B | USA |
 |
Sotera Health Company
SHC
|
250 M | $ 13.42 | 0.71 % | $ 3.81 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
OPKO Health
OPK
|
193 M | $ 1.19 | 2.59 % | $ 826 M | USA |